Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factors.
BACKGROUND
An increasing rate of respiratory colonization and infection in cystic fibrosis (CF) is caused by fungi of the Scedosporium apiospermum species complex or Lomentospora prolificans (Sac-Lp). These fungi rank second among the filamentous fungi colonizing the CF airways, after Aspergillus fumigatus. However, the epidemiology, clinical relevance and risk of pulmonary colonization with Sac-Lp are rarely understood in CF. The objective of the present prospective multicenter study was to study pathogen distribution and determine association factors of pulmonary Sac-Lp colonization in patients with CF.


METHODS
Clinical, microbiological and laboratory data of 161 patients aged 6-59 years with CF in Germany were analyzed for Sac-Lp distribution and association factors. The free statistical software R was utilized to investigate adjusted logistic regression models for association factors.


RESULTS
Of the 161 patients included in the study, 74 (56%) were male. The median age of the study cohort was 23 years (interquartile range 13-32 years). 58 patients of the total cohort (36%) were < 18 years old. Adjusted multivariate regression analysis revealed that Sac-Lp colonization was associated with younger age (OR 0.8684, 95%CI: 0.7955-0.9480, p<0.005) and less colonization with H. influenzae (OR 0.0118, 95%CI: 0.0009-0.1585, p<0.001). In addition, Sac-Lp-colonized patients had more often allergic bronchopulmonary aspergillosis (ABPA) (OR 14.6663, 95%CI: 2.1873-98.3403, p<0.01) and have been colonized more often with the mucoid phenotype of Pseudomonas aeruginosa (OR 9.8941, 95%CI: 1.0518-93.0705, p<0.05).


CONCLUSIONS
Newly found association of ABPA and Pseudomonas revealed new probable risk factors for Sac-Lp colonization. Allergy might play a role in inducing immunologic host reactions which lead to a less effective response to species of Sac-Lp.
Department of Pediatric Pneumology and Immunology, Cystic Fibrosis Center Berlin/Charité -Universitätsmedizin Berlin, Berlin, Germany.
Carsten
C
Schwarz
Department of Pediatric Pneumology and Immunology, Cystic Fibrosis Center Berlin/Charité -Universitätsmedizin Berlin, Berlin, Germany.
Claudia
C
Brandt
Reference Laboratory for Cryptococcosis, Scedosporiosis and Imported Systemic Mycoses, FG 16, Robert Koch Institute, Berlin, Germany.
Elisabeth
E
Antweiler
Biostatistics Unit, Berlin Institute of Health, Charité -Universitätsmedizin Berlin, Berlin, Germany.
Alexander
A
Krannich
Department of Pediatric Pneumology and Immunology, Cystic Fibrosis Center Berlin/Charité -Universitätsmedizin Berlin, Berlin, Germany.
Doris
D
Staab
Universitätsklinikum Bonn, Department of General Pediatrics, Bonn, Germany.
Sabina
S
Schmitt-Grohé
Privat Praxis West-München, Munich, Germany.
Rainald
R
Fischer
Universitätsklinikum für Kinder- und Jugendmedizin Tübingen, Department of General Pediatrics, Pediatric Hematology and Oncology, Tübingen, Germany.
Dominik
D
Hartl
Department of Pediatric Pneumology and Immunology, Cystic Fibrosis Center Berlin/Charité -Universitätsmedizin Berlin, Berlin, Germany.
Anja
A
Thronicke
Reference Laboratory for Cryptococcosis, Scedosporiosis and Imported Systemic Mycoses, FG 16, Robert Koch Institute, Berlin, Germany.
Kathrin
K
Tintelnot
D000293:Adolescent; D000328:Adult; D016022:Case-Control Studies; D002648:Child; D015331:Cohort Studies; D003550:Cystic Fibrosis / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology*; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D009894:Opportunistic Infections; D015995:Prevalence; D012042:Registries; D012129:Respiratory Function Tests; D012307:Risk Factors; D021681:Scedosporium / Q000145:classification; D055815:Young Adult